IRRIV International Renal Research Institute Vicenza
38th Vicenza Course on AKI and CRRT
38th Vicenza Course on AKI and CRRT
Septic AKI: Can Dialysis Membranes Be Used as a Therapeutic Approach?
FEATURING
Vincenzo Cantaluppi
- 154 views
- February 4, 2021
38th Vicenza Course on AKI and CRRT
Procoagulant State with COVID-19: Do We Need to Adapt Anticoagulation in CRRT?
FEATURING
Antoine G. Schneider
- 159 views
- February 3, 2021
38th Vicenza Course on AKI and CRRT
Citrate vs. Heparin Anticoagulation in CRRT: What to Recommend?
FEATURING
Dmytro Khadzhynov
- 136 views
- February 3, 2021
- 1
38th Vicenza Course on AKI and CRRT
The Clinical Path for CRRT NICU Adoption: How To Know When the Risks Outweigh the Benefits?
FEATURING
Stuart Goldstein
- 9 views
- February 3, 2021
38th Vicenza Course on AKI and CRRT
Cytokine Removal Therapy: What Is Its Role in The Treatment of Sepsis?
FEATURING
Fernando Sanchez Moran
- 103 views
- February 3, 2021
38th Vicenza Course on AKI and CRRT
Endotoxic Shock and COVID-19: What Is The Role of Polymyxin B Hemoperfusion?
FEATURING
Silvia De Rosa
- 10 views
- February 3, 2021
38th Vicenza Course on AKI and CRRT
What Is the Use of Biomarkers for the Management of AKI In the Critically Ill?
FEATURING
Lui G Forni
- 143 views
- February 3, 2021
38th Vicenza Course on AKI and CRRT
Can Biomarkers Be Utilized in the Management of Cardiac Surgery Associated AKI?
FEATURING
Daniel T. Engelman
- 85 views
- February 3, 2021
38th Vicenza Course on AKI and CRRT
Comparing AKI in Sepsis and AKI in Patients With COVID-19: What Are the Similarities and Differences?
FEATURING
Peter Pickkers
- 28 views
- February 3, 2021